checkAd

     193  0 Kommentare Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM) - Seite 2

    About Treatment.com AI Inc.

    Treatment.com AI is a company utilizing AI to positively disrupt the healthcare sector and impact current inefficiencies and challenges. Over the past 7+ years and with the input of hundreds of healthcare professionals globally, Treatment.com AI has built the world’s most intelligent, personalized healthcare AI engine, the Global Library of Medicine (GLM). Providing the highest qualified clinical information and support to all healthcare professionals, the GLM delivers >92%+ accuracy on first diagnosis as well as providing recommended tests (physical and lab), x-rays, and billing codes. The platform’s quality and transparency are unrivaled, as the GLM provides an explanation of every step and likelihood associated with every symptom. Treatment.com AI also focuses on the next generation of healthcare professionals supporting Medical and Nursing schools, who utilize the GLM to help enhance the future clinical skills of their students. Treatment.com AI is focused on using AI for good and utilizing its GLM platform to bring the possibility of health equity and inclusion for disenfranchised communities.

    About aiXplain Inc.

    Founded in 2020, aiXplain has established itself as a pioneering force with the industry's premier no-code/low-code platform for AI development. Designed to democratize the creation and deployment of AI solutions, our platform empowers users to effortlessly develop, manage, benchmark, and deploy AI solutions. With access to an expansive marketplace featuring over 40,000 leading AI models and assets, our customers are equipped to tailor advanced solutions to their specific needs, streamlining the path from concept to deployment. To learn more, visit aixplain.com.

    Media Contact
    LaunchSquad for aiXplain
    aixplain@launchsquad.com

    FOR ADDITIONAL INFORMATION, CONTACT:

    Dr. Essam Hamza, CEO

    Lesen Sie auch

    ehamza@treatment.com

    If you would like to find out more about Treatment’s products and services, please email at info@treatment.com

    For media inquiries, contact: media@treatment.com

    Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955

    Cautionary Statements

    This news release contains forward-looking statements that are based on Treatment.com AI’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

    The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.


    Seite 2 von 2



    globenewswire
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Verfasst von globenewswire
    Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM) - Seite 2 VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) - Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“aiXplain”) to enable …